Core Viewpoint - The company announced its annual profit distribution plan for 2024, detailing a cash dividend to shareholders based on the adjusted total share capital [1] Group 1 - The total share capital after deducting shares in the repurchase account is 4,222,239,474 shares [1] - The company will distribute a cash dividend of 1.4 yuan (including tax) for every 10 shares held [1] - There will be no bonus shares issued and no capital reserve conversion into shares [1] Group 2 - The record date for the distribution is set for August 14, 2025 [1] - The ex-dividend date is scheduled for August 15, 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 GOLDWIND SCIENCE&TECHNOLOGY CO., LTD.* 金風科技股份有限公司 ( 於中華人民共和國註冊成立的股份有限公司 ) (Stock Code: 02208) 海外監管公告 本公告乃根據《香港聯合交易所有限公司證券上市規則》第13.10B條而作出。 茲載列金風科技股份有限公司在深圳證券交易所網站刊登的《金風科技股份有限 公司關於 2024 年年度權益分派實施後調整 A 股股份回購價格上限的公告》，僅 供參閱。 承董事會命 金風科技股份有限公司 馬金儒 公司秘書 北京，2025年8月8日 於本公告日期，公司執行董事為武鋼先生及曹志剛先生；公司非執行董事為高建軍先生、楊 麗迎女士及張旭東先生；公司獨立非執行董事為曾憲芬先生、劉登清先生及苗兆光先生；及 公司職工代表董事為余寧女士。 *僅供識別 股票代码：002202 股票简称：金风科技 公告编号：2025-060 金风科技股份有限 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 GOLDWIND SCIENCE&TECHNOLOGY CO., LTD.* 金風科技股份有限公司 ( 於中華人民共和國註冊成立的股份有限公司 ) (Stock Code: 02208) 海外監管公告 本公告乃根據《香港聯合交易所有限公司證券上市規則》第13.10B條而作出。 茲載列金風科技股份有限公司在深圳證券交易所網站刊登的《金風科技股份有限 公司 2024 年年度權益分派 A 股實施公告》，僅供參閱。 承董事會命 金風科技股份有限公司 馬金儒 公司秘書 北京，2025年8月8日 於本公告日期，公司執行董事為武鋼先生及曹志剛先生；公司非執行董事為高建軍先生、楊 麗迎女士及張旭東先生；公司獨立非執行董事為曾憲芬先生、劉登清先生及苗兆光先生；及 公司職工代表董事為余寧女士。 *僅供識別 股票代码：002202 股票简称：金风科技 公告编号：2025-059 金风科技股份有限公司 2024 年年度权益分派 ...

GOLDWIND SCIENCE&TECHNOLOGY CO., LTD.* 金風科技股份有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 ( 於中華人民共和國註冊成立的股份有限公司 ) (Stock Code: 02208) 公告 末期股息派發 茲提述金風科技股份有限公司（「公司」）於 2025 年 3 月 28 日刊發之公告，內 容關於（其中包括）派發截至 2024 年 12 月 31 日止年度的末期股息，以總股本 4,225,067,647 股扣除公司回購專用證券帳戶中的 2,828,173 股後的餘額 4,222,239,474 股為基數，每 10 股派人民幣 1.4 元（含稅）（「2024 年度末期股 息」），以及於 2025 年 6 月 4 日刊發之 2024 年年度股東會通函（「年度股東會 通函」），內容關於（其中包括）召集公司 2024 年年度股東會（「年度股東會 」）以批准派發 2024 年度末期股息事項。 除文義另有所指， ...

股票代码：002202 股票简称：金风科技 公告编号：2025-059 金风科技股份有限公司 2024 年年度权益分派 A 股实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、根据《公司法》《深圳证券交易所上市公司自律监管指引第9 号——回购股份》等相关规定，上市公司回购专用账户中的股份不享 有利润分配等权利。截至本公告日，金风科技（以下简称"公司"） A股股本为3,451,495,248股，公司回购专用证券账户持有的公司A股 股份2,828,173股不参与本次权益分派。因此，公司2024年年度权益分 派以公司现有总股本4,225,067,647股扣除公司回购专用证券账户上 的 2,828,173 股 后 的 股 本 总 额 4,222,239,474 股 （其中 A 股 为 3,448,667,075，H股为773,572,399股）为基数，向全体股东每10股派发 现金红利1.4元（含税），不送红股，不以公积金转增股本。 2、自本次权益分派方案披露至实施期间，公司股本总额未发生 变化，本次权益分派采用固定比例的方式分配。 3、本次实施 ...

金风科技股份有限公司 关于2024年年度权益分派实施后调整A股股份回购价 格上限的公告 股票代码：002202 股票简称：金风科技 公告编号：2025-060 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、调整前回购股份价格上限：13.28 元/股； 2、调整后回购股份价格上限：13.14 元/股； 3、回购股份价格上限调整生效日期：2025 年 8 月 15 日。 一、关于回购 A 股股份的基本情况 金风科技（以下简称"公司"）第八届董事会第三十二次会议、 第八届监事会第十六次会议于 2025 年 4 月 25 日审议通过了《关于公 司以集中竞价交易方式回购公司 A 股股份的议案》，并经 2025 年 5 月 20 日召开的 2025 年第一次临时股东大会、2025 年第一次 A 股类 别股东会议及 2025 年第一次 H 股类别股东会议审议通过。 公司于 2025 年 5 月 21 日披露了《关于以集中竞价交易方式回购 公司股份的回购报告书》（以下简称"《回购报告书》"），公司拟 使用自有资金通过深圳证券交易所以集中竞价交易方式回购公司 ...

Group 1 - Harmony Health Insurance Co., Ltd. plans to reduce its stake in Goldwind Technology by up to 1% during the period from August 1 to October 31, 2025, which amounts to approximately 42.22 million shares [2][4] - The initial reason for the reduction is stated as financial needs of Harmony Health, with an estimated cash realization of about 427 million yuan based on the closing price of 10.11 yuan per share on July 10 [2][4] - This is not the first time Harmony Health has reduced its stake in Goldwind Technology this year, having previously sold over 12.58 million shares between March 17 and April 2 [4][5] Group 2 - As of the latest announcement, Harmony Health holds approximately 474 million shares of Goldwind Technology, representing about 11.21% of the total share capital after excluding shares in the repurchase account [4] - Goldwind Technology is one of the earliest companies in China to enter the wind power equipment manufacturing sector, with main businesses including wind turbine manufacturing, wind power services, and investment in wind farms [4] - The net profit attributable to shareholders of Goldwind Technology is projected to decline by 36.12% and 44.16% in 2022 and 2023, respectively, before a potential increase of 39.78% in 2024 [4] Group 3 - Harmony Health has also reduced its stakes in other A-share companies, including Wanda Information and Guangwei Composite, during the first quarter of this year [6] - The company is undergoing a transformation process to address existing risks and adjust its asset-liability structure, which includes a shift from equity investments to more stable fixed-income products [7][8] - The insurance industry is seeing a trend where approximately 70% of assets are allocated to fixed-income investments, reflecting a broader strategy among insurers to stabilize returns amid market fluctuations [8]

Group 1 - The core viewpoint of the article highlights the positive outlook for Goldwind Technology (02208), with its stock price rising over 8% due to favorable industry developments and government policies [1] - The National Development and Reform Commission's emphasis on breaking "involution" competition is expected to promote reforms in the bidding system for industries, including wind power, leading to a stabilization and potential increase in wind turbine prices [1] - The domestic wind power construction is accelerating, with good production and shipment performance in the supply chain since the first quarter, and a significant year-on-year increase in offshore wind power grid connection expected in the first half of 2025 [1] Group 2 - Citigroup recently reiterated a "buy" rating for Goldwind Technology, predicting that China's new wind power installations will exceed expectations, with an anticipated year-on-year growth of 38% to 120 GW for the year [1] - The grid connection volume is also expected to surpass 100 GW, higher than Citigroup's previous forecast of 90 GW, indicating strong market demand [1] - Citigroup anticipates a 10% increase in wind turbine bidding prices within the year, projecting Goldwind's sales gross margin to improve from 4% in 2024 to 7% and 10% in the following two years, raising the target price from 7.5 HKD to 9 HKD [1]

Group 1 - The core viewpoint of the article highlights the positive outlook for Goldwind Technology (金风科技) due to recent policy changes and market dynamics in the wind energy sector [1] - The National Development and Reform Commission's emphasis on breaking "involution" competition is expected to promote reforms in the bidding system for industries including wind power, leading to stabilization and potential increase in wind turbine prices [1] - The domestic wind power construction has accelerated, with good production and shipment performance in the supply chain since the beginning of the year, and a significant year-on-year increase in offshore wind power grid connection expected in the first half of 2025 [1] Group 2 - Citigroup has reiterated a "buy" rating for Goldwind Technology, forecasting that China's new wind power installations will exceed expectations, with an anticipated year-on-year growth of 38% to 120 GW for the year [1] - The grid connection volume is also expected to surpass 100 GW, exceeding Citigroup's previous forecast of 90 GW [1] - Citigroup anticipates a 10% increase in wind turbine bidding prices within the year, projecting Goldwind's sales gross margin to improve from 4% in 2024 to 7% and 10% in the following two years, raising the target price from 7.5 HKD to 9 HKD [1]

Core Viewpoint - Harmony Health Insurance Co., Ltd. plans to reduce its shareholding in Goldwind Technology Co., Ltd. by up to 42,222,394 shares, which is approximately 1% of the company's total share capital after excluding shares in the repurchase special account [1][2] Summary by Relevant Sections Shareholding Changes - Harmony Health's shareholding will decrease from 11.2146% to 10.9923% after the reduction of 9,384,542 shares [1][2] - The reduction will occur within a three-month period starting from August 1, 2025, to October 31, 2025, following a 15 trading day notice period [1][2] Compliance and Impact - The share reduction plan will not lead to a change in control of the company and will not significantly impact the company's governance structure or ongoing operations [1][2] - The actual number of shares reduced aligns with the previously disclosed reduction plan, indicating compliance with relevant regulations [2]